Guanidine Degradation Enzyme for Stable Cyanobacterial Ethylene

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Cyanobacterial strains face instability and toxicity due to guanidine accumulation as a byproduct of ethylene production, leading to inhibited growth and genomic instability.

Innovation Solution

Engineering cyanobacteria to express the bacterial ethylene-forming enzyme (EFE) alongside a guanidine degradation enzyme, Sll1077, which converts guanidine to non-toxic urea, enhancing genomic stability and enabling sustained ethylene production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If cyanobacteria are engineered to express high levels of ethylene-forming enzyme (EFE), then ethylene production is enhanced, but guanidine accumulation causes genomic instability and growth inhibition

Engineering Contradiction:

Improveethylene productionVSAvoidgenomic stability

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The harmful byproduct guanidine is removed from the system by introducing a guanidine degradation pathway. The gene sll1077 encoding guanidine deiminase is expressed to convert accumulated guanidine into less toxic compounds, effectively extracting the harmful substance that causes genomic instability while allowing high-level EFE expression to continue

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The toxic guanidine byproduct is converted into a beneficial situation by introducing the degradation enzyme. The same guanidine that causes genomic instability is now metabolized through the sll1077 pathway, transforming a harmful accumulation into a controlled metabolic flux that supports sustained ethylene production without toxicity

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

2Productivity

If cyanobacteria are engineered to express high levels of ethylene-forming enzyme (EFE), then ethylene production is enhanced, but cell growth is inhibited due to guanidine toxicity

Engineering Contradiction:

Improveethylene productionVSAvoidcell growth

Core Design Contradiction:

ProductivityVSStability of the object's composition

Solution Approach 1:

The guanidine deiminase enzyme encoded by sll1077 acts as an intermediary that mediates between ethylene production and cell growth. It processes the intermediate guanidine compound, preventing its toxic accumulation and allowing both high ethylene production and healthy cell growth to coexist

Inventive Principle:

Principle #24Intermediary (Mediator)

3Duration of action of moving object

If guanidine is allowed to accumulate as a byproduct, then ethylene production is sustained, but the strain exhibits genomic instability

Engineering Contradiction:

Improveethylene production durationVSAvoidgenomic stability

Core Design Contradiction:

Duration of action of moving objectVSReliability

Solution Approach 1:

The guanidine degradation pathway operates continuously to process guanidine as it accumulates during ethylene production. This continuous removal of toxic byproducts maintains genomic stability throughout the production process, enabling sustained ethylene production without the detrimental effects of guanidine accumulation

Inventive Principle:

Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered strains achieve stable ethylene production and improved tolerance to guanidine, allowing for efficient guanidine degradation and utilization as a nitrogen source, with enhanced cell growth and reduced toxicity.

Implementation Method 1

Co-expression of EFE and Sll1077 significantly enhanced genomic stability and enabled the resulting Synechococcus strain GD-EFE7942 to achieve sustained high-level ethylene production

Methodology Applied

Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS12448632B2Guanidine degradation enzyme and methods of use

Publication Date: 2025.10.21 VANDERBILT UNIV

AI summary

Presented herein are Synechococcus strains engineered to express the bacterial ethylene-forming enzyme (EFE) that exhibit unstable ethylene production due to toxicity and genomic instability induced by accumulation of the EFE-byproduct guanidine. Co-expression of EFE and Sll1077 significantly enhanced genomic stability and enabled the resulting Synechococcus strain GD-EFE7942 to achieve sustained high-level ethylene production. The engineered strains and methods disclosed herein are useful for guanidine degradation pathways and for ethylene bioproduction in cyanobacteria.